logo

Exhibiting at FOOD INGREDIENTS CHINA 2025

41D00/41F01
NECC (Shanghai)
17 Mar - 19 Mar, 2025

Product Offerings

Product Categories:

Pharmaceutical Ingredients, pharmaceutical products, active pharmaceutical ingredients (apis), pharmaceutical ingredients, Active Pharmaceutical Ingredients, Animal Nutrition, Food Additives and Ingredients, pharmaceuticals, health supplements, healthcare products, Nutritional Products, antibiotics, vitamins, animal nutrition, Human Nutrition

Products:

Life Nutrition Products: Synthetic Vitamin E, Natural Vitamin E, Beta-Carotene, Cantharidin, Coenzyme Q10, Lutein, Lycopene

Pharmaceutical Products: Vancomycin Hydrochloride, Teicoplanin, Levofloxacin Lactate Injection, Anti-infective Drugs, Glucosidase Inhibitors, Immunosuppressants

Animal Nutrition Products: Various animal nutritional supplements

Product Gallery:

Zhejiang Medicine Co., Ltd.(浙江医药股份有限公司), headquartered in Shaoxing, China, is a publicly listed biopharmaceutical and life sciences company with a diversified portfolio in human and animal health, nutrition, and pharmaceutical active ingredients. As one of China’s leading vitamin manufacturers and an established pharmaceutical producer, the company has been instrumental in supplying essential molecules and formulations to global markets for decades.

Core Business and Product Offerings

Zhejiang Medicine operates across three primary segments:

  • Life Nutrition Products

    • Synthetic Vitamin E
    • Natural Vitamin E
    • Beta-Carotene
    • Cantharidin
    • Coenzyme Q10
    • Lutein
    • Lycopene
  • Pharmaceutical Products

    • Vancomycin Hydrochloride
    • Teicoplanin
    • Levofloxacin Lactate Injection
    • Anti-infective Drugs (e.g., beta-lactam antibiotics)
    • Glucosidase Inhibitors
    • Immunosuppressants
  • Animal Nutrition Products

    • Feed-grade vitamins and health-enhancing additives

These products are used in:

  • Dietary supplements and fortified foods
  • Prescription and over-the-counter pharmaceuticals
  • Veterinary nutrition and feed applications

Specialization and Unique Selling Proposition

Zhejiang Medicine’s core competencies include:

  • Vitamin E Production Leadership – One of the world’s largest producers of synthetic Vitamin E.
  • Integrated API Manufacturing – Full production chain from raw intermediates to finished APIs.
  • GMP-compliant Pharmaceutical Facilities – Produces human-grade antibiotics and specialty drugs.
  • Advanced Carotenoid Extraction and Synthesis – Offers stable and bioavailable forms of lutein, beta-carotene, and lycopene.

The company holds a strategic advantage due to:

  • Scale production capacity
  • Diversified market reach across pharmaceuticals, nutrition, and animal health
  • Strong R&D capabilities and intellectual property development

Target Market

Zhejiang Medicine supplies products to:

  • Global dietary supplement brands
  • Pharmaceutical manufacturers and hospitals
  • Veterinary product formulators
  • Functional food and beverage companies

The company exports to over 60 countries, including:

  • United States
  • Germany
  • India
  • Brazil
  • Japan
  • Russia

Manufacturing Capabilities and Infrastructure

The company operates multiple production bases in Zhejiang Province with:

  • GMP-certified pharmaceutical plants
  • High-capacity vitamin and carotenoid production lines
  • Dedicated R&D centers for drug synthesis, fermentation, and formulation development

Key facilities include:

  • Shaoxing Base (Pharmaceutical APIs and preparations)
  • Xinchang Base (Nutrition and feed-grade vitamins)
  • Tongxiang Base (High-tech development and pilot production)

Zhejiang Medicine invests heavily in automation and environmental protection measures across its plants.

Certifications and Compliance

Zhejiang Medicine’s facilities and products comply with international standards:

  • GMP (China, EU, US FDA compliant facilities)
  • ISO 9001 Quality Management
  • ISO 14001 Environmental Management
  • OHSAS 18001 Occupational Health & Safety
  • FAMI-QS and Feed Additive Approvals
  • CEP (Certificate of Suitability to Monographs of the European Pharmacopoeia)
  • FDA DMFs (Drug Master Files) and COS

Financial and Shipment Records

Zhejiang Medicine Co., Ltd. is listed on the Shanghai Stock Exchange (Stock Code: 600216) and reported the following key financial metrics:

  • 2022 Revenue: Over RMB 6.9 billion (~USD 1 billion)
  • Net Profit: RMB 520+ million
  • Vitamin E exports: Over 20,000 MT annually, making it a top 3 global exporter

According to shipment data from Volza and ImportYeti:

  • Frequent export shipments of Coenzyme Q10, synthetic Vitamin E, and APIs to North America and Europe
  • Major buyers include pharmaceutical companies, nutritional product manufacturers, and chemical distributors

Major Achievements

  • Among the top global producers of Vitamin E and CoQ10
  • Developed indigenous production processes for high-purity APIs such as Vancomycin
  • Recognized as a National Key High-Tech Enterprise in China
  • Collaborated with research institutions for novel drug delivery systems and anti-infective research

Customer Testimonials

“Zhejiang Medicine’s synthetic Vitamin E is a benchmark in quality and price competitiveness. We’ve sourced it for over a decade.”
Global Sourcing Manager, Nutraceutical Brand, USA

“Their APIs meet strict EU compliance standards and are always delivered with complete documentation and regulatory support.”
Regulatory Affairs Director, Pharmaceutical Company, Germany

Zhejiang Medicine Co., Ltd. remains a cornerstone of China’s health industry exports, blending pharmaceutical excellence with life science innovation to serve global human and animal wellness.